University of Ottawa Institute of Mental Health Research, Ottawa, ON, Canada.
Neuroscience. 2010 Oct 27;170(3):816-26. doi: 10.1016/j.neuroscience.2010.07.012. Epub 2010 Jul 17.
Sensory gating impairment in schizophrenia has been documented in the form of aberrant middle latency P50 event-related brain potential responses to S(1) and/or S(2) stimuli in a paired (S(1)-S(2)) auditory stimulus paradigm. Evidenced by a failure to suppress S(2) P50 or by attenuated S(1) P50s, these sensory deficits have been associated with increased smoking behaviour in this disorder, and may be related to the putative ameliorating effects of smoke-inhaled nicotine on neural mechanisms regulating gating. Comparison of healthy controls with low versus high gating efficiency has been forwarded as a model for investigating the actions of antipsychotic agents on aberrant gating functions. In the current study, the effect of a single dose (6 mg) of nicotine gum on P50, gating indices, and their cortical sources indexed with sLORETA (standardized low resolution electromagnetic tomography), was examined in healthy non-smokers (n=24) stratified for low and high gating levels. Scalp surface recordings revealed nicotine modulation of P50 and its gating to be differentially exhibited in high (decreasing gating) and low (increasing gating) suppressors while the underlying cortical sources influenced by nicotine (middle frontal gyrus, inferior/superior parietal lobules, pre- and post-central gyri) were seen only in low suppressors. These findings suggest that nicotine impacts sensory gating in healthy volunteers and as the gating enhancing effects were dependent on low baseline gating efficiency, nicotinic receptor agonists may be associated with unique P50 modulating actions in schizophrenia.
精神分裂症的感觉门控障碍已在 S(1)-S(2)听觉刺激范式中以异常的中间潜伏期 P50 事件相关脑电位对 S(1)和/或 S(2)刺激的反应形式记录下来。这些感觉缺陷表现为 S(2) P50 无法抑制或 S(1) P50 减弱,与该障碍中吸烟行为增加有关,并且可能与烟雾吸入尼古丁对调节门控的神经机制的假定改善作用有关。将健康对照者与低门控效率与高门控效率进行比较,被提出作为研究抗精神病药物对异常门控功能作用的模型。在当前的研究中,在健康不吸烟者(n=24)中,根据低门控水平和高水平分层,检查了尼古丁口香糖(6 毫克)对 P50、门控指数及其皮质源的影响,使用 sLORETA(标准化低分辨率电磁断层扫描)进行评估。头皮表面记录显示,尼古丁对 P50 及其门控的调节在高(门控降低)和低(门控增强)抑制剂中表现出不同,而受尼古丁影响的皮质源(中额回、下/上顶叶、额前和中央回)仅在低抑制剂中可见。这些发现表明,尼古丁对健康志愿者的感觉门控有影响,并且由于门控增强作用依赖于低基线门控效率,烟碱受体激动剂可能与精神分裂症中独特的 P50 调节作用有关。